Discover 575 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 575
QTX3034 in Patients With KRAS G12D Mutation
for
Solid Tumors
Location: Oklahoma City OK, Houston TX, San Antonio TX, Denver CO,
Sponsor: Quanta Therapeutics
Sex: All
Age: 18+
Code: NCT06227377
Phase1, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Oklahoma City OK, Dallas TX, Kansas City KS, Omaha NE,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase1, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Oklahoma City OK, Dallas TX, Kansas City MO, Austin TX,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
for
KRAS G12C Mutation, KRAS G12S Mutation,
Location: Oklahoma City OK, San Antonio TX, Denver CO,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT06720987
Phase1, Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Oklahoma City OK, Dallas TX, Fort Worth TX, Omaha NE,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Oklahoma City OK, Wichita KS, Dallas TX, Westwood KS,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for
Endometrial Adenocarcinoma
Location: Oklahoma City OK, Kansas City MO, Little Rock AR,
Sponsor: Acrivon Therapeutics
Sex: Female
Age: 18+
Code: NCT05548296
Phase2, Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
for
Cervical Cancer
Location: Oklahoma City OK, Bedford TX, Dallas TX, Fort Worth TX,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT04831580
Recruiting
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
for
Pneumococcal Disease
Location: Oklahoma City OK, Shreveport LA, Chicago IL,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT07573462
Phase3, Recruiting
Analgesic Comparison of PENG/LFCN to FICB for Total Hip Arthroplasty
for
Analgesia
Location: Oklahoma City OK
Sponsor: SSM Health Bone and Joint Hospital at St Anthony
Sex: All
Age: 40 - 70+
Code: NCT05477641
Recruiting
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
for
Non Small Cell Lung Cancer
Location: Oklahoma City OK, Springdale AR, Little Rock AR,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312137
Phase3, Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Location: Oklahoma City OK, Dallas TX, Tyler TX, Memphis TN,
Sponsor: Merus B.V.
Sex: All
Age: 18+
Code: NCT03526835
Phase1, Phase2, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Oklahoma City OK, Dallas TX, Arlington TX, Tyler TX,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase3, Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
for
Peripheral Artery Disease (PAD)
Location: Oklahoma City OK, Plano TX, DeSoto TX, Amarillo TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318610
Phase3, Recruiting
Prospective Study to Assess a Diagnostic Aid for Cancer
for
Cancer
Location: Oklahoma City OK, Hutchinson KS, Kansas City MO,
Sponsor: Harbinger Health
Sex: All
Age: 45+
Code: NCT07046260
Recruiting
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
for
Cancer Weight Loss
Location: Oklahoma City OK, Wichita KS, Lincoln NE, Omaha NE,
Sponsor: Endevica Bio
Sex: All
Age: 18+
Code: NCT06937177
Phase2, Recruiting
New
Designing Effective Alcohol Health Warnings: An Experimental Study With Adults in the U.S.
for
Risk Perceptions, Decision Making, Alcohol
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: Female
Age: 18 - 65
Code: NCT07812545
Recruiting
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
for
CRC Screening, CRC (Colorectal Cancer)
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 45 - 70+
Code: NCT07254910
Recruiting
Connect2Care: Prostate Cancer Education and Screenings for African American Men
for
Prostate Cancer, Health Behavior
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: Male
Age: 45 - 69
Code: NCT07055165
Recruiting
A Culturally Tailored Smartphone Application for African American Smokers